SOPHiA GENETICS (SOPH) CTO sells 3,549 shares under Rule 10b5-1 tax plan

Rhea-AI Filing Summary

SOPHiA GENETICS SA Chief Technology Officer Abhimanyu Verma reported open-market sales of a total of 3,549 Ordinary Shares to cover tax obligations from recently vested restricted stock units. The sales on April 6 and 7, 2026 were executed under a pre-established Rule 10b5-1 trading plan and are described as non-discretionary.

After these transactions, Verma directly holds 204,400 Ordinary Shares.

Insights

Insider transactions analyst

Routine, pre-planned tax-related insider sales with modest size.

The Chief Technology Officer sold 3,549 Ordinary Shares of SOPHiA GENETICS SA in open-market transactions at weighted average prices around $4.86. Footnotes state the sales were solely to satisfy tax withholding obligations from restricted stock unit vesting.

The filing notes these transactions were made under a pre-established Rule 10b5-1 trading plan and characterized as non-discretionary, which typically reduces the informational value of the timing. Following the sales, the CTO still holds 204,400 Ordinary Shares directly, indicating the activity represents a small portion of his overall equity position.

Insider Trade Summary 10b5-1

Net Seller: 3,549 shares ($17,256)

Net Sell 2 txns

Insider Verma Abhimanyu

Role Chief Technology Officer

Sold 3,549 shs ($17K)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares	1,030	$4.8701	$5K
Sale	Ordinary Shares	2,519	$4.859	$12K

Holdings After Transaction: Ordinary Shares — 204,400 shares (Direct)

Footnotes (1)

1. Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.71 to $4.95, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.74 to $4.96, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold total: 3,549 shares First transaction size: 1,030 shares Second transaction size: 2,519 shares +3 more

6 metrics

Shares sold total 3,549 shares Open-market sales on April 6–7, 2026

First transaction size 1,030 shares Sold at weighted average $4.8701 per share

Second transaction size 2,519 shares Sold at weighted average $4.8590 per share

Price range April 7 $4.71–$4.95 Multiple trades aggregated into weighted average price

Price range April 6 $4.74–$4.96 Multiple trades aggregated into weighted average price

Shares held after transactions 204,400 shares Direct ownership following April 2026 sales

Key Terms

Rule 10b5-1 trading plan, restricted stock units, tax withholding obligations, weighted average price

4 terms

Rule 10b5-1 trading plan financial

"These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

restricted stock units financial

"tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting"

weighted average price financial

"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Verma Abhimanyu

(Last) (First) (Middle)

C/O SOPHIA GENETICS SA

LA PIECE 12

(Street)

ROLLE 1180

(City) (State) (Zip)

SWITZERLAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
SOPHiA GENETICS SA [ SOPH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	04/06/2026		S		2,519(1)	D	$4.859(2)	205,430	D
Ordinary Shares	04/07/2026		S		1,030(1)	D	$4.8701(3)	204,400	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.71 to $4.95, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.74 to $4.96, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Elimara Brunetto as Attorney-in-fact for Abhimanyu Verma	04/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did SOPH Chief Technology Officer Abhimanyu Verma report?

Abhimanyu Verma reported selling 3,549 Ordinary Shares of SOPHiA GENETICS SA in open-market transactions. The sales occurred on April 6 and 7, 2026 at weighted average prices around $4.86 per share, according to the Form 4 filing footnotes.

Why did SOPH CTO Abhimanyu Verma sell 3,549 shares of SOPHiA GENETICS?

The shares were sold to satisfy tax withholding obligations arising from restricted stock units that vested on April 2 and 3, 2026. The filing states these sales were purely for tax withholding purposes rather than discretionary portfolio decisions by the CTO.

Were Abhimanyu Verma’s SOPH share sales made under a Rule 10b5-1 plan?

Yes. The Form 4 footnotes explain that the sales were executed pursuant to a pre-established Rule 10b5-1 trading plan. Such plans are set up in advance and are designed to execute trades automatically, reducing the insider’s discretion over timing.

How many SOPH shares does CTO Abhimanyu Verma hold after these transactions?

After completing the reported transactions, Abhimanyu Verma directly holds 204,400 Ordinary Shares of SOPHiA GENETICS SA. This post-transaction ownership figure shows that the 3,549 shares sold represent a relatively small portion of his overall stake.

What prices were received in the recent SOPH insider share sales?

The reported weighted average prices were $4.8701 and $4.8590 per share for the two sales. Footnotes add that individual trades occurred in ranges of $4.71–$4.95 and $4.74–$4.96, and detailed breakdowns are available upon written request.